Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma in Older Adults.
| Data(s) |
01/02/2016
|
|---|---|
| Formato |
191 - 205 |
| Identificador |
http://www.ncbi.nlm.nih.gov/pubmed/26614868 S0749-0690(15)00080-4 Clin Geriatr Med, 2016, 32 (1), pp. 191 - 205 http://hdl.handle.net/10161/11590 1879-8853 |
| Relação |
Clin Geriatr Med 10.1016/j.cger.2015.08.012 |
| Palavras-Chave | #Cancer #Elderly #Geriatric #MGUS #Multiple myeloma #Neoplasm #Older adult #Aged #Aged, 80 and over #Comorbidity #Geriatric Assessment #Health Status Indicators #Humans #Monoclonal Gammopathy of Undetermined Significance #Multiple Myeloma #Risk Factors |
| Tipo |
Journal Article |
| Cobertura |
United States |
| Resumo |
Multiple myeloma (MM) and monoclonal gammopathy of undetermined significance (MGUS) are plasma cell disorders of aging. The landscape of the diagnosis and management of MM and MGUS are rapidly changing. This article provides an updated understanding of the clinical presentation, evaluation, diagnosis, and management of older adults with MM and MGUS. Because most oncology providers are not formally trained in geriatric medicine, geriatricians play a key role in providing oncologists with a broader understanding of patient health status in the hope of improving outcomes for older adults with MM. |
| Idioma(s) |
ENG |
